SYNH
Income statement / Annual
Last year (2022), Syneos Health, Inc.'s total revenue was $5.39 B,
an increase of 3.46% from the previous year.
In 2022, Syneos Health, Inc.'s net income was $266.50 M.
See Syneos Health, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
FY-2013
|
| Period Ended |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
12/31/2013 |
| Operating Revenue |
$5.39 B
|
$5.21 B
|
$4.42 B
|
$4.68 B
|
$4.39 B
|
$2.67 B
|
$1.61 B
|
$1.40 B
|
$1.18 B
|
$995.09 M
|
| Cost of Revenue |
$4.14 B |
$3.99 B |
$3.40 B |
$3.65 B |
$3.43 B |
$2.05 B |
$1.21 B |
$1.03 B |
$884.13 M |
$774.93 M |
| Gross Profit |
$1.25 B |
$1.22 B |
$1.02 B |
$1.03 B |
$955.81 M |
$620.82 M |
$403.70 M |
$372.34 M |
$294.67 M |
$220.16 M |
| Gross Profit Ratio |
0.23 |
0.23 |
0.23 |
0.22 |
0.22 |
0.23 |
0.25 |
0.27 |
0.25 |
0.22 |
| Research and Development
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| General & Administrative
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$406.31 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$547.25 M
|
$570.77 M
|
$442.48 M
|
$446.28 M
|
$406.31 M
|
$282.62 M
|
$172.39 M
|
$156.61 M
|
$145.14 M
|
$117.89 M
|
| Other Expenses |
$247.18 M |
$235.63 M |
$222.35 M |
$242.47 M |
$28.24 M |
-$19.85 M |
-$9.00 M |
$3.86 M |
$7.69 M |
$120,000.00 |
| Operating Expenses |
$794.43 M |
$806.39 M |
$664.84 M |
$688.75 M |
$679.99 M |
$462.56 M |
$231.59 M |
$212.62 M |
$199.69 M |
$176.36 M |
| Cost And Expenses |
$4.93 B |
$4.80 B |
$4.06 B |
$4.33 B |
$4.11 B |
$2.51 B |
$1.44 B |
$1.24 B |
$1.08 B |
$951.30 M |
| Interest Income |
$1.61 M |
$111,000.00 |
$265,000.00 |
$7.54 M |
$3.69 M |
$1.18 M |
$216,000.00 |
$192,000.00 |
$249,000.00 |
$310,000.00 |
| Interest Expense |
$80.79 M |
$79.14 M |
$90.88 M |
$129.82 M |
$130.70 M |
$63.73 M |
$12.02 M |
$15.64 M |
$53.04 M |
$60.80 M |
| Depreciation &
Amortization |
$296.80 M
|
$267.07 M
|
$284.98 M
|
$242.47 M
|
$273.69 M
|
$179.94 M
|
$59.20 M
|
$56.01 M
|
$54.54 M
|
$58.47 M
|
| EBITDA |
$699.99 M
|
$656.35 M
|
$578.13 M
|
$567.01 M
|
$581.43 M
|
$319.54 M
|
$219.39 M
|
$218.14 M
|
$149.56 M
|
$102.19 M
|
| EBITDA Ratio |
0.13 |
0.13 |
0.13 |
0.12 |
0.13 |
0.12 |
0.14 |
0.16 |
0.13 |
0.1 |
| Operating Income Ratio
|
0.07
|
0.07
|
0.07
|
0.07
|
0.04
|
-0.01
|
0.1
|
0.11
|
0.05
|
0.03
|
| Total Other
Income/Expenses Net |
-$88.63 M
|
-$74.12 M
|
-$89.49 M
|
-$136.05 M
|
-$102.92 M
|
-$83.01 M
|
-$21.24 M
|
-$21.39 M
|
-$91.85 M
|
-$62.14 M
|
| Income Before Tax |
$314.57 M |
$315.16 M |
$203.66 M |
$101.71 M |
$57.26 M |
-$111.88 M |
$134.12 M |
$130.97 M |
-$28.20 M |
-$30.68 M |
| Income Before Tax Ratio
|
0.06
|
0.06
|
0.05
|
0.02
|
0.01
|
-0.04
|
0.08
|
0.09
|
-0.02
|
-0.03
|
| Income Tax Expense |
$48.07 M |
$80.33 M |
$10.87 M |
-$29.55 M |
$32.97 M |
$26.59 M |
$21.49 M |
$13.93 M |
-$4.73 M |
$10.85 M |
| Net Income |
$266.50 M |
$234.83 M |
$192.79 M |
$131.26 M |
$24.28 M |
-$138.47 M |
$112.63 M |
$117.05 M |
-$23.47 M |
-$41.53 M |
| Net Income Ratio |
0.05 |
0.05 |
0.04 |
0.03 |
0.01 |
-0.05 |
0.07 |
0.08 |
-0.02 |
-0.04 |
| EPS |
2.57 |
2.26 |
1.85 |
1.27 |
0.23 |
-1.85 |
2.08 |
2.02 |
-0.44 |
-0.8 |
| EPS Diluted |
2.54 |
2.24 |
1.83 |
1.25 |
0.23 |
-1.85 |
2.03 |
1.95 |
-0.44 |
-0.8 |
| Weighted Average Shares
Out |
$102.97 M
|
$103.87 M
|
$104.17 M
|
$103.62 M
|
$103.41 M
|
$74.91 M
|
$54.03 M
|
$57.89 M
|
$53.30 M
|
$52.01 M
|
| Weighted Average Shares
Out Diluted |
$103.48 M
|
$105.07 M
|
$105.47 M
|
$105.01 M
|
$104.70 M
|
$74.91 M
|
$55.61 M
|
$60.15 M
|
$53.30 M
|
$52.01 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
